FDA SAFETY WARNING: Prolia | Medical News Bulletin

Osteoporosis patients with chronic kidney disease using Prolia have a higher risk of developing dangerously low calcium levels, leading to severe harm, including life-threatening events and death. Patients should be aware of symptoms such as confusion, irregular heart rhythm, and muscle spasms. It is important to have regular check-ups and maintain calcium and vitamin D levels while using Prolia. Do not stop taking the medication without consulting a doctor, as the risk of rebound fractures is high. With proper monitoring and care, most patients can still use Prolia safely, but it is important to discuss potential alternative treatments with a healthcare provider.

Source link

error: Content is protected !!